These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

560 related items for PubMed ID: 26455324

  • 1. Genome-wide screen identified let-7c/miR-99a/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinoma.
    Lin KY, Ye H, Han BW, Wang WT, Wei PP, He B, Li XJ, Chen YQ.
    Oncogene; 2016 Jun 30; 35(26):3376-86. PubMed ID: 26455324
    [Abstract] [Full Text] [Related]

  • 2. Let-7c inhibits cholangiocarcinoma growth but promotes tumor cell invasion and growth at extrahepatic sites.
    Xie Y, Zhang H, Guo XJ, Feng YC, He RZ, Li X, Yu S, Zhao Y, Shen M, Zhu F, Wang X, Wang M, Balakrishnan A, Ott M, Peng F, Qin RY.
    Cell Death Dis; 2018 Feb 14; 9(2):249. PubMed ID: 29445149
    [Abstract] [Full Text] [Related]

  • 3. MiR-124 induces autophagy-related cell death in cholangiocarcinoma cells through direct targeting of the EZH2-STAT3 signaling axis.
    Ma J, Weng L, Wang Z, Jia Y, Liu B, Wu S, Cao Y, Sun X, Yin X, Shang M, Mao A.
    Exp Cell Res; 2018 May 15; 366(2):103-113. PubMed ID: 29530475
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
    Yang R, Chen Y, Tang C, Li H, Wang B, Yan Q, Hu J, Zou S.
    BMC Cancer; 2014 Dec 05; 14():917. PubMed ID: 25479763
    [Abstract] [Full Text] [Related]

  • 5. Expression and clinical significance of interleukin-6 pathway in cholangiocarcinoma.
    Gu D, Zhao X, Song J, Xiao J, Zhang L, Deng G, Li D.
    Front Immunol; 2024 Dec 05; 15():1374967. PubMed ID: 38881895
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.
    Liu B, Hu Y, Qin L, Peng XB, Huang YX.
    Dig Liver Dis; 2019 Mar 05; 51(3):397-411. PubMed ID: 30314946
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X, Xia M, Chen D, Wu F, Lv Z, Zhan Q, Jiao Y, Wang W, Chen G, An F.
    Tumour Biol; 2016 Nov 05; 37(11):15019-15029. PubMed ID: 27658773
    [Abstract] [Full Text] [Related]

  • 14. Upregulated microRNA-194 impairs stemness of cholangiocarcinoma cells through the Rho pathway via inhibition of ECT2.
    Gao J, Dai C, Yu X, Yin XB, Zhou F.
    J Cell Biochem; 2020 Oct 05; 121(10):4239-4250. PubMed ID: 31960990
    [Abstract] [Full Text] [Related]

  • 15. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.
    Zhu H, Mi Y, Jiang X, Zhou X, Li R, Wei Z, Jiang H, Lu J, Sun X.
    J Cancer Res Clin Oncol; 2016 May 05; 142(5):969-80. PubMed ID: 26825606
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The microRNA-15a-PAI-2 axis in cholangiocarcinoma-associated fibroblasts promotes migration of cancer cells.
    Utaijaratrasmi P, Vaeteewoottacharn K, Tsunematsu T, Jamjantra P, Wongkham S, Pairojkul C, Khuntikeo N, Ishimaru N, Sirivatanauksorn Y, Pongpaibul A, Thuwajit P, Thuwajit C, Kudo Y.
    Mol Cancer; 2018 Jan 18; 17(1):10. PubMed ID: 29347950
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MicroRNA-551b-3p inhibits tumour growth of human cholangiocarcinoma by targeting Cyclin D1.
    Chang W, Wang Y, Li W, Shi L, Geng Z.
    J Cell Mol Med; 2019 Aug 18; 23(8):4945-4954. PubMed ID: 31199052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.